Globus Medical, Inc. (GMED)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 10:28AM EDT. Market open.
| Previous close | 51.36 |
| Open | 58.20 |
| Bid | 63.97 x 800 |
| Ask | 64.09 x 800 |
| Day's range | 59.20 - 64.73 |
| 52-week range | 43.39 - 64.73 |
| Volume | |
| Avg. volume | 1,049,155 |
| Market cap | 8.543B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 59.12 |
| EPS (TTM) | 1.07 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 61.46 |
ZacksGlobus Medical (GMED) Q1 Earnings Top Estimates, Margins Fall
Globus Medical (GMED) delivers massive sales and earnings growth in the first quarter of 2024.
ZacksGlobus Medical (GMED) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ZacksGlobus Medical (GMED) Q1 Earnings and Revenues Beat Estimates
Globus Medical (GMED) delivered earnings and revenue surprises of 30.91% and 3.41%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.